GLP-1 receptor agonists, a class of medications originally developed for type 2 diabetes and now prescribed for weight loss, are affecting sexual desire in ways that surprise both patients and doctors. Some men report increased libido, others decreased interest in sex. Scientists are now investigating the biological mechanisms behind these shifts, and the findings matter if you're considering these drugs or already taking them.
New research is exploring how GLP-1 agonists interact with dopamine and other neurotransmitters that regulate sexual function and motivation. The exact mechanism remains under study, but early evidence suggests these drugs influence both the neurological and metabolic pathways that drive sexual interest. Because GLP-1 use is expanding rapidly beyond diabetes treatment, understanding these side effects is becoming a public health priority.
If you're on a GLP-1 and notice changes in sexual desire or function, talk to your prescriber before stopping the medication. In some cases, the effect stabilizes over time. In others, dosing adjustments or switching medications may help. Sexual side effects are real, and they're worth addressing directly with a healthcare provider, not ignoring.
At B Brand, we recognize that sexual health isn't one-size-fits-all, which is why we offer personalized provider consultations for ED treatment and other sexual wellness concerns alongside your other healthcare needs.
Featured Products
Stay current on men's sexual health.
New articles, research updates, and treatment guides delivered to your inbox.
No spam. Unsubscribe anytime.
